TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday

TriSalus Life Sciences Inc (NASDAQ: TLSI) shares increased by 5.8% to $5.22 following the announcement of FDA 510(k) clearance for its TriNav Advance product. In a broader market context, the Nasdaq Composite fell over 100 points on the same day. Other notable gainers included Lakefront Biotherapeutics (NASDAQ: LKFT), which rose 6.8% to $32.24 after an upgrade from RBC Capital, and Editas Medicine (NASDAQ: EDIT), which climbed 4% to $3.04 following an upgrade from Guggenheim.